A prospective evaluation of the utility of 2-deoxy-2-[18F] fluoro- D -glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer

Cancer

Volumn 118, Issue 22, 2012, Pages 5481-5488

  Smyth, Elizabeth ^a   Schöder, Heiko ^a   Strong, Vivian E ^a   Capanu, Marinela ^a   Kelsen, David P ^a   Coit, Daniel G ^a   Shah, Manish A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

economic model; gastric cancer; laparoscopy; positron emission tomography; tumor staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CYTODIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; LAPAROSCOPY; LOCALLY ADVANCED GASTRIC CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; MODELS, ECONOMIC; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PATIENT CARE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 84868192110     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27550     Document Type: Review

References (33)

1. Cunningham D, Allum WH, Stenning SP, et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355: 11-20.
2. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001; 345: 725-730.
3. Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report-a phase iii multicenter, prospective, randomized trial (KLASS Trial). Ann Surg. 2010; 251: 417-420.
4. Ajani JA, Barthel JS, Bekaii-Saab T, et al. NCCN Gastric Cancer Panel. Gastric cancer. J Natl Compr Canc Netw. 2010; 8: 378-409.
5. Pan L, Gu P, Huang G, Xue H, Wu S,. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2009; 21: 1008-1015.
6. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol. 2001; 19: 3058-3065.
7. Ott K, Weber WA, Lordick F, et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2006; 24: 4692-4698.
8. Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 2007; 8: 797-805.
9. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000; 18: 3202-3210.
10. Heeren PA, Jager PL, Bongaerts F, van Dullemen H, Sluiter W, Plukker JT,. Detection of distant metastases in esophageal cancer with 18F-FDG PET. J Nucl Med. 2004; 45: 980-987.
11. Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K,. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg. 2004; 28: 247-253.
12. Koga H, Sasaki M, Kuwabara Y, et al. An analysis of the physiological FDG uptake pattern in the stomach. Ann Nucl Med. 2003; 17: 733-738.
13. Takahashi H, Ukawa K, Ohkawa N, et al. Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography. Ann Nucl Med. 2009; 23: 391-397.
14. Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S,. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer. 2006; 9: 192-196.
15. Kim EY, Lee WJ, Choi D, et al. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol. 2011; 79: 183-188.
16. Yang QM, Kawamura T, Itoh H, et al. Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology. 2008; 55: 782-785.
17. Lim JS, Kim MJ, Yun MJ, et al. Comparison of CT and 18F-FDG PET for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol. 2006; 7: 249-256.
18. Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004; 230: 465-471.
19. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991; 181: 426-432.
20. Catalano MF, Sivak MV Jr, Rice T, Gragg LA, Van Dam J,. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994; 40: 442-446.
21. Greene FL, Page DL, Fleming ID, et al, editors. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6th edition. New York, NY: Springer-Verlag; 2002.
22. Burke EC, Karpeh MS, Conlon KC, Brennan MF,. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997; 225: 262-267.
23. Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS,. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 2006; 191: 134-138.
24. Power DG, Schattner MA, Gerdes H, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009; 208: 173-178.
25. Wang Z, Chen JQ,. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol. 2011; 11: 19.
26. Duarte I, Llanos O,. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol. 1981; 12: 237-242.
27. Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging. 2003; 30: 288-295.
28. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277-2284.
29. Sarela AI, Yelluri S,; for the Leeds Upper Gastrointestinal Cancer Multidisciplinary Team. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg. 2007; 142: 143-149.
30. Dalal K, Woo Y, Kelly K, et al. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer. 2008; 11: 206-213.
31. Keereweer S, Kerrebijn J, van Driel P, et al. Optical Image-guided Surgery-Where Do We Stand? Mol Imaging Biol. 2011; 13: 199-207.
32. Iwatsuki M, Fukagawa T, Mimori K, et al. Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis. Br J Cancer. 2009; 100: 1937-1942.
33. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol. 2008; 15: 3092-3100.